Free Newsletter
MIT study offers advance in stem cell therapy
A group of MIT researchers have been developing a new process to enhance the effectiveness of transplanting bone marrow cells to the site of a fracture. While the procedure has been done some 40,000 times, it's often marred by rejection. The new research uses a scaffold to hold epidermal growth factor molecules that can promote the growth and differentiation of stem cells. New research published in Stem Cells suggests that the process improved cell survival and increased proliferation. Further research is being done on animal models. Their goal is direct implantation into patients.
- read the report from MIT's Technology Review
Related Articles:
Breast cancer stem cells found in bone marrow. Report
New method spurs proliferation of adult stem cells. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: